mastodon.nu är en av de många oberoende Mastodon-servrar som du kan använda för att delta i Fediversen.
Mastodon.nu etablerades 2021 och är den största servern i Norden samt öppen för alla. Den drivs ideellt på ett professionellt vis och med 100% förnybar energi. Välkommen! Velkommen! Tervetuloa!

Administrerad av:

Serverstatistik:

1,6K
aktiva användare

#NovoNordisk

0 inlägg0 deltagare0 inlägg i dag
Mediapart<p>La cynique alliance de la malbouffe et du grand laboratoire prétendant lutter contre l’obésité </p><p><a href="https://mediapart.social/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a> commercialise des médicaments amaigrissants et, officiellement, la fondation du laboratoire se mobilise pour prévenir l’obésité. La réalité est tout autre. Son vice-président a par exemple été payé par Ferrero, Nestlé, McDonald’s et McCain. </p><p>› <a href="https://www.mediapart.fr/journal/france/050425/la-cynique-alliance-de-la-malbouffe-et-du-grand-laboratoire-pretendant-lutter-contre-l-obesite?at_medium=rs-cm&amp;at_campaign=mastodon&amp;at_account=mediapart" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">mediapart.fr/journal/france/05</span><span class="invisible">0425/la-cynique-alliance-de-la-malbouffe-et-du-grand-laboratoire-pretendant-lutter-contre-l-obesite?at_medium=rs-cm&amp;at_campaign=mastodon&amp;at_account=mediapart</span></a></p>
Aboumael ⏚🔻🇺🇦 🇵🇸<p>[Médiapart] - La cynique alliance de la malbouffe et du grand laboratoire prétendant lutter contre l’obésité</p><p><a href="https://piaille.fr/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a> commercialise des médicaments amaigrissants et, officiellement, la fondation du laboratoire se mobilise pour prévenir l’obésité. La réalité est tout autre. Son vice-président a par exemple été payé par <a href="https://piaille.fr/tags/Ferrero" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Ferrero</span></a>, <a href="https://piaille.fr/tags/Nestl%C3%A9" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Nestlé</span></a>, <a href="https://piaille.fr/tags/McDonald" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>McDonald</span></a>’s et <a href="https://piaille.fr/tags/McCain" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>McCain</span></a>.</p><p><a href="https://www.mediapart.fr/journal/france/050425/la-cynique-alliance-de-la-malbouffe-et-du-grand-laboratoire-pretendant-lutter-contre-l-obesite" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">mediapart.fr/journal/france/05</span><span class="invisible">0425/la-cynique-alliance-de-la-malbouffe-et-du-grand-laboratoire-pretendant-lutter-contre-l-obesite</span></a></p><p><a href="https://piaille.fr/tags/ob%C3%A9sit%C3%A9" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>obésité</span></a> <a href="https://piaille.fr/tags/Malbouffe" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Malbouffe</span></a> <br><a href="https://piaille.fr/tags/Sant%C3%A9" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Santé</span></a> <a href="https://piaille.fr/tags/Health" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Health</span></a> <a href="https://piaille.fr/tags/RevueDePresse" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>RevueDePresse</span></a> <a href="https://piaille.fr/tags/Press" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Press</span></a></p>
Europe Says<p><a href="https://www.europesays.com/1939039/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="">europesays.com/1939039/</span><span class="invisible"></span></a> SAP has just become Europe’s most valuable company, dethroning Novo Nordisk <a href="https://pubeurope.com/tags/europe" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>europe</span></a> <a href="https://pubeurope.com/tags/MarketCapitalisation" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>MarketCapitalisation</span></a> <a href="https://pubeurope.com/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a> <a href="https://pubeurope.com/tags/SAP" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>SAP</span></a> <a href="https://pubeurope.com/tags/Shares" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Shares</span></a> <a href="https://pubeurope.com/tags/StockExchange" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>StockExchange</span></a></p>
Teslagauss1884<p><span class="h-card" translate="no"><a href="https://mediapart.social/@mediapart" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>mediapart</span></a></span> <br>Aussi ne prenez pas d ozempic a moins d'avoir des problèmes extrêmement particulier. Ce médicament fout en l'air les centres de la récompense et perturbent les centres de la joie . Et ça peut provoquer des gastroparesie. Soit une immobilisation du système digestif<br><a href="https://rivals.space/tags/ozempic" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ozempic</span></a> <a href="https://rivals.space/tags/novonordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>novonordisk</span></a></p>
Börsposten<p>Novo Nordisk-aktien har rasat över 40 procent från toppen, köp säger Dagens industri <a href="https://borsposten.se/novo-nordisk-aktien-har-rasat-over-40-procent-fran-toppen-kop-sager-dagens-industri/" target="_blank" rel="nofollow noopener noreferrer" translate="no"><span class="invisible">https://</span><span class="ellipsis">borsposten.se/novo-nordisk-akt</span><span class="invisible">ien-har-rasat-over-40-procent-fran-toppen-kop-sager-dagens-industri/</span></a> <a href="https://mastodon.nu/tags/aktier" class="mention hashtag" rel="tag">#<span>aktier</span></a> <a href="https://mastodon.nu/tags/NovoNordisk" class="mention hashtag" rel="tag">#<span>NovoNordisk</span></a></p>
Ben Royce 🇺🇦<p><span class="h-card" translate="no"><a href="https://sfba.social/@pmonks" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>pmonks</span></a></span> <span class="h-card" translate="no"><a href="https://m.ai6yr.org/@ai6yr" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>ai6yr</span></a></span> </p><p><a href="https://mastodon.social/tags/Denmark" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Denmark</span></a> <a href="https://mastodon.social/tags/Trump" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Trump</span></a> <a href="https://mastodon.social/tags/Ozempic" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Ozempic</span></a> <a href="https://mastodon.social/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a></p>
Glyn Moody<p>The King of <a href="https://mastodon.social/tags/Ozempic" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Ozempic</span></a> Is Scared as Hell - <a href="https://www.wired.com/story/novo-nordisk-king-of-ozempic-scared-as-hell/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">wired.com/story/novo-nordisk-k</span><span class="invisible">ing-of-ozempic-scared-as-hell/</span></a> "Now that <a href="https://mastodon.social/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a> is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?"</p>
J. Steven York RESISTS<p>Update on the insulin situation. I had a new prescription for a different insulin Monday morning. I was able to pick it up a couple hours later and immediately get my daily shot, about ten hours late, which isn't critical for me. No problems so far, and I like the functionality of the injector pen much better than the old Novo Nordisk one, which was cranky and sometimes difficult to inject, even for a guy with big, fairly strong, hands.</p><p><a href="https://mastodon.social/tags/usHealthCare" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>usHealthCare</span></a> <a href="https://mastodon.social/tags/novoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>novoNordisk</span></a> <a href="https://mastodon.social/tags/insulin" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>insulin</span></a> <a href="https://mastodon.social/tags/diabetes" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>diabetes</span></a></p>
J. Steven York RESISTS<p>And if you're considering taking Ozempic for weight loss, let me say that while the side-effects are probably worth it if you're a diabetic like me, I can't imagine doing it just hoping to lose a few pounds. There have to be easier ways than all the time I spend in the bathroom, imposed dietary limitations, and dealing with other digestive impact. <br><a href="https://mastodon.social/tags/usHealthCare" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>usHealthCare</span></a> <a href="https://mastodon.social/tags/pharma" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>pharma</span></a> <a href="https://mastodon.social/tags/novoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>novoNordisk</span></a> <a href="https://mastodon.social/tags/insulin" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>insulin</span></a> <a href="https://mastodon.social/tags/diabetes" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>diabetes</span></a> <a href="https://mastodon.social/tags/ozempic" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ozempic</span></a></p>
J. Steven York RESISTS<p>So why, you ask, was Levimir discontinued? Maker Novo Nordisk got upset about insulin price laws and decided they could make more money making Ozempic (which ironically I ALSO take, for diabetes, not for weight loss). Why is access to insulin seemingly controlled as much (or more) than opioids? I suspect it's because of rules and state laws that were likely written by big-pharma lobbyists to control the trade.<br><a href="https://mastodon.social/tags/usHealthCare" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>usHealthCare</span></a> <a href="https://mastodon.social/tags/pharma" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>pharma</span></a> <a href="https://mastodon.social/tags/novoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>novoNordisk</span></a> <a href="https://mastodon.social/tags/insulin" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>insulin</span></a> <a href="https://mastodon.social/tags/diabetes" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>diabetes</span></a> <a href="https://mastodon.social/tags/ozempic" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ozempic</span></a> <a href="https://mastodon.social/tags/levimir" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>levimir</span></a></p>
J. Steven York RESISTS<p>Discontinued insulin update: Got a call back from Urgent Care. Absolutely NOTHING can be done before Monday (Small, isolated town, limited medical resources) before Monday unless I go to the emergency room (on a busy saturday night in a tourist town), wait forever in Covid Town, and pay a $100 copay for other people's incompetence. I'll skip my Sunday night shot and hope i can get it fixed before too late on monday.<br><a href="https://mastodon.social/tags/diabetes" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>diabetes</span></a> <a href="https://mastodon.social/tags/usmedicalcare" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>usmedicalcare</span></a> <a href="https://mastodon.social/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a> <a href="https://mastodon.social/tags/insulin" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>insulin</span></a></p>
☮ ♥ ♬ 🧑‍💻<p>“A fourth factor in <a href="https://ioc.exchange/tags/Nordic" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Nordic</span></a> outperformance is patient shareholders. According to <a href="https://ioc.exchange/tags/McKinsey" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>McKinsey</span></a>, a consultancy, four-fifths of large Nordic companies have long-term ownership, compared with three-fifths in Europe and only a fifth in America. Business dynasties play a prominent role in the region. <a href="https://ioc.exchange/tags/Maersk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Maersk</span></a> and <a href="https://ioc.exchange/tags/Lego" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Lego</span></a> are still controlled, respectively, by the founding Moller and Kristiansen families, though both firms are run day-to-day by outsiders. In <a href="https://ioc.exchange/tags/Sweden" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Sweden</span></a> the Wallenbergs, whose fortune originated in banking, own large stakes in various companies, including <a href="https://ioc.exchange/tags/AtlasCopco" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AtlasCopco</span></a> and <a href="https://ioc.exchange/tags/Ericsson" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Ericsson</span></a>. Other big Nordic firms, including <a href="https://ioc.exchange/tags/Carlsberg" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Carlsberg</span></a> and <a href="https://ioc.exchange/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a>, are controlled by non-profit foundations.</p><p>Such arrangements have prevented foreign firms from snapping up Nordic companies, giving them more time to grow. They have also made it easier for companies to invest in their long-term success. McKinsey reckons that four-fifths of listed Nordic companies spend more on <a href="https://ioc.exchange/tags/research" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>research</span></a> and <a href="https://ioc.exchange/tags/development" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>development</span></a> than their rivals do elsewhere in the West. Lars Fruergaard Jorgensen, Novo Nordisk’s boss, has said that his main focus is how the company will look in ten to 20 years”</p><p><a href="https://ioc.exchange/tags/business" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>business</span></a> / <a href="https://ioc.exchange/tags/stability" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>stability</span></a> / <a href="https://ioc.exchange/tags/technology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>technology</span></a> &lt;<a href="http://active.econweb.p.aws.economist.com/business/2024/12/30/why-are-nordic-companies-so-successful" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">http://</span><span class="ellipsis">active.econweb.p.aws.economist</span><span class="invisible">.com/business/2024/12/30/why-are-nordic-companies-so-successful</span></a>&gt;</p>
Börsposten<p>Nordnets kunder bottenfiskade Novo Nordisk och Evolution under december <a href="https://borsposten.se/nordnets-kunder-bottenfiskade-novo-nordisk-och-evolution-under-december/" target="_blank" rel="nofollow noopener noreferrer" translate="no"><span class="invisible">https://</span><span class="ellipsis">borsposten.se/nordnets-kunder-</span><span class="invisible">bottenfiskade-novo-nordisk-och-evolution-under-december/</span></a> <a href="https://mastodon.nu/tags/aktier" class="mention hashtag" rel="tag">#<span>aktier</span></a> <a href="https://mastodon.nu/tags/NovoNordisk" class="mention hashtag" rel="tag">#<span>NovoNordisk</span></a> <a href="https://mastodon.nu/tags/EvolutionGaming" class="mention hashtag" rel="tag">#<span>EvolutionGaming</span></a></p>
Johan Saxe<p>Är börsen öppen idag?</p><p>Ja det är den. Kul då kan vi handla aktier igen. Novo Nordisk sticker uppåt efter sin kraftiga dipp.<br />Köpte ni i dippen?</p><p><a href="https://mastodon.nu/tags/b%C3%B6rs" class="mention hashtag" rel="tag">#<span>börs</span></a> <a href="https://mastodon.nu/tags/aktie" class="mention hashtag" rel="tag">#<span>aktie</span></a> <a href="https://mastodon.nu/tags/NovoNordisk" class="mention hashtag" rel="tag">#<span>NovoNordisk</span></a> <a href="https://mastodon.nu/tags/nvo" class="mention hashtag" rel="tag">#<span>nvo</span></a></p>
Juha Haataja<p>Pörssikurssi laihtui?</p><p>"Testissä olleen uuden laihdutuslääkkeen Cagriseman odotettiin pudottavan tutkimuksessa mukana olleiden painoa 25 prosenttia tutkimuksen aikana. Heidän painonsa kuitenkin putosi keskimäärin vain alle 23 prosenttia. ... Pörssikurssit reagoivat tulokseen lähtemällä parinkymmenen prosentin syöksyyn."</p><p><a href="https://mastodon.social/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a> </p><p><a href="https://yle.fi/a/74-20132987" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="">yle.fi/a/74-20132987</span><span class="invisible"></span></a></p>
Benjamin Carr, Ph.D. 👨🏻‍💻🧬<p><a href="https://hachyderm.io/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a> sells hit <a href="https://hachyderm.io/tags/weight" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>weight</span></a>-loss drug in <a href="https://hachyderm.io/tags/China" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>China</span></a>—at fraction of US price<br>As US struggles to afford <a href="https://hachyderm.io/tags/GLP1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GLP1</span></a> <a href="https://hachyderm.io/tags/drugs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>drugs</span></a>, the rest of the world sees much lower prices.<br><a href="https://arstechnica.com/health/2024/11/novo-nordisk-sells-hit-weight-loss-drug-in-china-at-fraction-of-us-price/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">arstechnica.com/health/2024/11</span><span class="invisible">/novo-nordisk-sells-hit-weight-loss-drug-in-china-at-fraction-of-us-price/</span></a></p>
The Japan Times<p>Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted strong third-quarter earnings despite being held back by production constraints. <a href="https://www.japantimes.co.jp/business/2024/11/06/obesity-drugmaker-novo-nordisk-profit/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">japantimes.co.jp/business/2024</span><span class="invisible">/11/06/obesity-drugmaker-novo-nordisk-profit/</span></a> <a href="https://mastodon.social/tags/business" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>business</span></a> <a href="https://mastodon.social/tags/novonordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>novonordisk</span></a> <a href="https://mastodon.social/tags/ozempic" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ozempic</span></a> <a href="https://mastodon.social/tags/wegovy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>wegovy</span></a></p>
gtbarry<p>With Novo Nordisk success, is there a "Nokia risk" for Denmark?</p><p>Novo Nordisk's success with Wegovy and Ozempic has led to huge profits: its current market capitalization is larger than Denmark's entire GDP. </p><p>"The risk here is that this is one sector. There are dangers that come with having one sector be so dependent for so much growth."</p><p><a href="https://mastodon.social/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a> <a href="https://mastodon.social/tags/Wegovy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Wegovy</span></a> <a href="https://mastodon.social/tags/Ozempic" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Ozempic</span></a> <a href="https://mastodon.social/tags/Denmark" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Denmark</span></a> <a href="https://mastodon.social/tags/Nokia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Nokia</span></a> <a href="https://mastodon.social/tags/Finland" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Finland</span></a> <a href="https://mastodon.social/tags/pharmaceuticals" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>pharmaceuticals</span></a> <a href="https://mastodon.social/tags/Biotech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Biotech</span></a> <a href="https://mastodon.social/tags/GLP1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GLP1</span></a> <a href="https://mastodon.social/tags/economics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>economics</span></a> <a href="https://mastodon.social/tags/GDP" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GDP</span></a> <a href="https://mastodon.social/tags/business" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>business</span></a></p><p><a href="https://www.cbsnews.com/news/with-novo-nordisk-success-is-there-a-nokia-risk-for-denmark-60-minutes/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">cbsnews.com/news/with-novo-nor</span><span class="invisible">disk-success-is-there-a-nokia-risk-for-denmark-60-minutes/</span></a></p>
Glyn Moody<p>Weight-loss drug firm accused of prioritising profits after halting insulin pen production - <a href="https://www.theguardian.com/global-development/2024/oct/16/weight-loss-drug-firm-novo-nordisk-insulin-pen-production" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">theguardian.com/global-develop</span><span class="invisible">ment/2024/oct/16/weight-loss-drug-firm-novo-nordisk-insulin-pen-production</span></a> "<a href="https://mastodon.social/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a>’s decision will force people in developing countries to use outdated glass vials and syringes, warn campaigners" typically shabby greed</p>
Thomas Hansen 🐧<p>Novo Nordisk gør fandeme ikke noget godt for at afkræfte de konspiratoriske typers konspirationsteorier om medicinalindustriens indflydelse ... <a href="https://social.data.coop/tags/novonordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>novonordisk</span></a> <a href="https://social.data.coop/tags/konspirationsteori" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>konspirationsteori</span></a></p><p>"Bekymrede politikere efter DR's Novo-afsløring: 'Det er helt uacceptabelt'. Flere politikere er bekymrede over tætte forbindelser mellem Novo Nordisk og et offentligt hospital, som DR har afsløret."</p><p>📰 <a href="https://www.dr.dk/nyheder/indland/bekymrede-politikere-efter-drs-novo-afsloering-det-er-helt-uacceptabelt" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">dr.dk/nyheder/indland/bekymred</span><span class="invisible">e-politikere-efter-drs-novo-afsloering-det-er-helt-uacceptabelt</span></a></p>